T he transradial access (TRA) site has been adopted as the preferred access site for percutaneous coronary intervention (PCI) in the United Kingdom and many countries across Europe. 1-3 TRA is associated with decreased mortality rates in specific patient groups, 4-8 at least in part through a reduction in major bleeding complications. 9 Radial access is technically more challenging than femoral and has a longer learning curve requiring higher volumes to achieve and maintain proficiency. 10, 11 Procedural volume for PCI at both the operator and the institutional level has been linked both to improved mortality and procedural outcomes. 12, 13 Similarly, procedural volume and expertise may equally be important for outcomes associated with TRA utilization. Data derived from the radial versus femoral trial (A Trial of Trans-Radial Versus
Unstable Angina or Myocardial Infarction Managed With an
Invasive Strategy [RIVAL]), that randomized 7021 patients with acute coronary syndromes to radial versus femoral access for PCI, suggest that procedural radial volumes may impact on PCI outcomes associated with the TRA utilization. 14, 15 Although in the subgroup of high-volume radial centers the primary outcome was reduced by adoption of TRA, this was not observed in intermediate-or low-volume radial centers, and furthermore there was no significant interaction by individual operator radial volume (ORV). 14 Although previous work has studied the relationship between center and ORV and its relationship between access site-related outcomes, 15, 16 these data have some limitations. First, some data are derived in the setting of randomized controlled trials, therefore in highly selected patient cohorts in whom PCIs were undertaken in experienced centers with experienced operators. 14, 15 Second, data are derived from centers in North America where procedural center volumes of ≥50 TRA procedures per year (defined as high-volume radial centers) would be considered low volume in countries where TRA represents the default access site (such as the United Kingdom). Although center and operator TRA volumes may be considered markers of TRA expertise, this will clearly be dependent on total PCI center and operator volumes, hence high-volume centers and operators who only do a small proportion of their cases through the TRA route would numerically still be considered as experienced high-volume radial centers/operators in previous analyses. The proportion of cases undertaken through the TRA is an important marker of radial experience and expertise because high-proportion TRA operators will undertake PCI cases through the TRA in the most challenging cases but this has not been considered or adjusted for in previous analyses. Often such patients are at the highest risk of bleeding complications and derive most benefit from the TRA approach. 5 We have, therefore, studied the relationship between access site practice and clinical outcomes in the United Kingdom and how this relationship may be associated with operator and center experience/expertise, as defined by both the volume and proportion of cases undertaken through the TRA. Furthermore, we also study the clinical characteristics and procedural demographics of patients in whom TRA is the access site adopted for PCI by operators/centers with differing degrees of TRA experience/practice.
Methods

The British Cardiovascular Intervention Society Database
The British Cardiovascular Intervention Society (BCIS) collects data on all PCI procedures in the United Kingdom, [17] [18] [19] and data collection is coordinated by the National Institute of Cardiovascular Outcomes Research (http://www.ucl.ac.uk/nicor/) via the Central Cardiac Audit Database. In 2011, this data set collected information on 99.4% of all PCI procedures performed in National Health Service Hospitals in England and Wales. The BCIS-National Institute of Cardiovascular Outcomes Research database comprises 113 variables, including clinical variables, procedural parameters, and patient outcomes. Mortality tracking is undertaken by the Medical Research Information Service using patients' National Health Service numbers that provide a unique identifier for any person registered with the National Health Service in England and Wales.
Study Definitions
The data presented relate to all reported PCI procedures undertaken in patients in England and Wales between January 1, 2012 and December 31, 2013. PCI procedures performed via the left or right femoral artery or the left or right radial artery were included in the transfemoral access (TFA) and TRA cohorts, respectively. Procedures involving a switch from one access site to another, or where access site was unknown, were excluded. The outcomes examined were in-hospital major adverse cardiovascular events (MACE; a composite of in-hospital mortality and in-hospital myocardial infarction (MI) or reinfarction and target vessel revascularization), in-hospital major bleeding (defined as gastrointestinal bleed, intracerebral bleed, retroperitoneal hematoma, blood or platelet transfusion, or an arterial access site complication requiring surgery), and 30-day mortality.
Statistical Methods
Descriptive
Three measures of operator experience were considered: the yearly operator total volume (OTV), the yearly ORV, and the yearly operator radial proportion (ORP=ORV/OTV). Analogous annualized measures of center experience, center total volume (CTV), center radial volume (CRV), center radial proportion (CRP), were also considered. TRA proportion was plotted against volume for operator and for center to examine
WHAT IS KNOWN
• The transradial access site has become the default access site for percutaneous coronary intervention in Europe and it is rapidly growing in adoption within the United States.
• Procedural volume for percutaneous coronary intervention at both the operator and institutional level has been linked both to mortality and procedural outcomes.
• Procedural volume and expertise may equally be important for outcomes associated with access site.
WHAT THE STUDY ADDS
• This study found significant variation in access site selection at both the individual operator and center level and according to volume of procedures undertaken.
• Transradial access was used more often because operator/center volume increased.
• We demonstrated lower mortality with transradial access and that benefit relates to the proportion of procedures undertaken through the radial approach, and also the total volume of procedures, with operators undertaking the greatest proportion of their procedures radially having the largest relative reduction in mortality risk.
• We observed no association between mortality and either total or radial volume at the center level once adjustment was made for other covariates of patient clinical demographics and operator experience. their relationships. Individual operator identity was derived from a unique General Medical Council number derived from the BCIS data set available from 2012 that each medical practitioner licensed to practice medicine in the United Kingdom is allocated when first registered with the General Medical Council. It is a statuary requirement to be registered with the General Medical Council to practice medicine in the United Kingdom.
To examine the relationship between case mix and experience, cases were divided into 4 groups according to each of these 3 measures; quartiles defined the group boundaries for the OTV, ORV, CTV, and CRV, and boundaries for ORP and CRP were at values of 25%, 50%, and 75%. Important aspects of case mix (eg, variables such as age, shock) were then tabulated per group against access site. These tables were presented with column percentages for categorical variables, which can be interpreted as an indication of how case mix varies by access site. To test for association between demographic and clinical variables and access site choice within strata, t tests were used for continuous variables and χ 2 tests for categorical variables. Logistic regression was used to determine whether access site choice differed between experience groups; Access site (TRA only or TFA only) was the binary outcome, and we report the P value from the test of inclusion of an interaction term between the demographic/ clinical variable and experience group.
Modeling
Logistic regression was used for each outcome (30-day mortality, major bleeding, and MACE). The exposures of interest were access site, operator/center experience, and the interactions between access site and experience. Models were adjusted for demographic and clinical confounders. Two strategies were used to deal with intrapatient dependencies, with analyzes from each strategy performed in parallel; the first strategy assumed that all procedures were independent so that no design modifications were necessary, whereas the second permitted only the first procedure for each patient during the study period to enter the analysis cohort. After removing observations where the exposure was missing, multiple imputation was implemented. Ten data sets were imputed in total and the models developed on each of these were pooled using Rubin rules. 20 The same 10 data sets were used for each outcome analysis so that each analysis was drawn from the same imputation model and to eliminate the need to reimpute for each outcome. To allow for this, each of the 3 outcome variables were included in the chained imputation equations but crucially, at the model development and analysis stage observations were removed if the outcome of interest was originally missing, that is, a multiple imputation then deletion strategy. 21 Clinical and demographic confounders were chosen previously based on availability and clinical relevance: age, sex, year of operation, indication for treatment (stable angina, unstable angina/non-ST-elevated MI, ST-elevated MI), presence of diabetes mellitus, renal function, coronary artery bypass graft, shock, intra-aortic balloon pump, cardiopulmonary support, inotropic support, ventilation, stent type, smoking status, high cholesterol, previous MI, left ventricular ejection fraction, and use of glycoprotein IIb/ IIIa drugs were all adjusted for. First-order interactions were considered.
Models were considered which combined all 3 measures of experience (along with interactions with access site). Models adjusting for a single measure of experience were also examined, with and then without adjusting for other covariates. Nonlinear effects were considered for the measures of experience via restricted cubic splines with 4 knots. 22 Odds ratios (OR) comparing odds of adverse outcomes for radial access with odds for femoral access site were plotted against each measure of experience, along with 95% confidence intervals (CIs), for the models considered.
A secondary analysis was performed to investigate if the experience-outcome relationships observed in the primary analysis were still present when restricting to noncardiogenic procedures.
Software
All data preparation and analyses were performed using R version 3.2.0. 23 The mice package 24 was used for multiple imputation. 
Results
Study Cohort
A total of 164 395 procedures were performed in patients in England and Wales between January 1, 2012 and December 31 2013, and the influence of operator and CTV, radial volume, and radial proportions on outcomes was studied. Figure 1 illustrates a flowchart that tracks the process by which observations are removed from the analysis cohorts and the stages at which experience measures are calculated. Experience measure and the descriptive analysis was performed in 149 165 procedures. Among these, operators are typically high-proportion radial or high-proportion femoral with few operators performing around 50% of each, with high-volume centers more likely to be high-proportion radial centers (Figure 2) . During the study period, radial proportion increased steadily from 60.4% in January to March 2012 to 70.1% in October to December 2013 as illustrated in Figure 3 .
In total, 145 250 procedures were used in the primary mortality analysis. Restricting the analysis cohort to patients undergoing their first procedure during the study period removed 13 055 (9%) procedures from full cohort, with results from this cohort versus the full cohort practically equivalent. We therefore only present results from the analysis of the full cohort.
Operator and Center Volumes and Access Site-Related Outcomes
The influence of operator and center volumes on access siterelated outcomes was studied. Table 1 illustrates clinical and procedural demographics for the TRA and TFA groups by operator annual procedural volumes. Table 1 shows that because operator volume increased across groups, TRA increased from 54.3% in lowest OTV group (≤124 procedures) to 72.9% in the highest OTV group (>237 procedures); P<0.001. Patients in the TFA cohort were consistently older, were more likely to be female sex, have a history of coronary artery bypass grafting, have a history of MI, have diabetes mellitus, be hypertensive, and present with cardiogenic shock (all P<0.001) in all operator volume groups studied. Similar observations were recorded when center volume was studied ( Table 2) . Table 2 illustrates clinical and procedural demographics for the TRA and TFA groups by CTV. TRA utilization increased from 57.6% in the lowest CTV group (≤682 procedures) to 76.0% in the highest CTV group (>1633 procedures), P<0.001.
Crude 30-day mortality outcomes were significantly fewer in the TRA cohort compared with the TFA cohort across all volume groups studied both at the operator level (1.6% versus 3.9% in lowest operator volume group, 1.6% versus 4.9% in the highest operator volume group; P<0.001) and at the center volume level (1.2% versus 2.6% in the lowest center volume group, 1.6% versus 5.1% in the highest center volume group; P<0.001). Similar observations were recorded for both in-hospital MACE and major bleeding complications (Tables 1 and 2 ).
Operator and CRPs and Access Site-Related Outcomes
The relationship between ORP, CRP, and access site-related outcomes was studied. Tables 3 and 4 illustrate clinical and procedural demographics for the TRA and TFA groups stratified by radial proportion quartiles at the operator and center level respectively.
Crude 30-day mortality rates by access site (ie, TRA versus TFA) were similar in the low ORP cohort defined as undertaking <25% of PCI procedures through the TRA route (TRA, 2.2% and TFA, 2.4%; P=0.561) but were significantly less in the TRA group compared with the TFA group in the remaining ORP groups (mortality in highest ORP, TRA, 1.7% and TFA, 7.2%; P<0.001). In-hospital major bleeding and MACE was significantly lower in the TRA cohort compared with TFA cohort in all ORP groups studied, with this effect larger for MACE in high-proportion radial operators (P<0.001) but not for bleeding (P=0.676). When crude 30-day mortality was studied according to CRP, similar findings were observed except that the effect of TRA versus TFA was not different by proportion groups for bleeding (P<0.001; Table 4 ). BMS indicates bare metal stent; CRP, center radial proportion; DES, drug eluting stent; LVEF, left ventricular ejection fraction; MACE, major adverse cardiovascular events; NSTEMI, non-ST-segment-elevated myocardial infarction; SD, standard deviation; STEMI, ST-segment-elevated myocardial infarction; TFA, transfemoral access; TRA, transradial access; and UA, unstable angina. Volume and Access Site-Related Outcomes
Operator and CRV and Access Site-Related Outcomes
We subsequently studied the influence of ORV and CRV on outcomes. Table I in the Data Supplement illustrates clinical and procedural demographics and clinical outcomes stratified by ORV group. Patients in the TFA cohort were consistently older, had a higher prevalence of comorbidities, and were more likely to present with hemodynamic compromise in all ORV groups studied. Similar observations were recorded when CRV was studied ( Table II in the  Data Supplement) .
TRA was associated with lower crude 30-day mortality compared with TFA in all quartiles of operator and CRV studied (P<0.001).
Adjusted Analyses for Operator/Center Volumes and Proportions
Multiple logistic regression modeling for each experience measure independently indicated that experience increase was significantly associated with reductions in the TRA versus TFA OR for 30-day mortality, after adjustment for confounders. Figure I in the Data Supplement illustrates and quantifies these associations for each of the experience measures.
Multiple logistic regression modeling adjusting for other experience measures in addition to confounders showed an average odds reduction of 39% for 30-day mortality for TRA when compared with TFA (OR, 0.61; 95% CI, 0.55-0.68; P<0.001), and indicated that only increasing OTV and ORP were significantly associated with reductions in the TRA versus TFA OR for 30-day mortality. Figure 4 illustrates and quantifies these associations for each of the experience measures. The magnitude of this risk reduction was modified by increases in OPV (OR reduction of 11% per 100 extra procedures; 95% CI, 3%-19%) and by increases in ORV (OR reduction of 6% per 10%-point increase in radial proportion; 95% CI, 1%-11%) with no significant OR changes when varying by ORV, CTV, CRV, and CRP.
Sensitivity analyses for these regression models indicated that although some confounder interactions were significant, additional adjustments did not materially affect the exposure parameters of interest; therefore, interactions between confounders were not included. Furthermore, nonlinear experience effects were investigated via restricted cubic splines and although some nonlinearities were observed, these were often in low operator/center density spaces where model uncertainty is high, and made no practical difference to the principal observation that OTV and ORP are negatively associated with the TRA versus TFA mortality OR after adjustment for confounders and other experience measures. The exclusion of repeat admission during the study period to ensure independence between patients did not significantly alter the results of the primary analysis (compare Figure 4 with Figure II in the Data Supplement).
Similarly restricting the analysis to PCI procedures undertaken in the noncardiogenic shock setting, we demonstrate similar findings to the results for the whole cohort ( Figure III in the Data Supplement).
Discussion
Our analysis of around 150 000 PCI procedures undertaken nationally between 2012 and 2013 suggests that there is significant variation in access site practice at both the individual operator and center level according to volume of procedures undertaken, with TRA used more commonly as operator/center volume increase. We report that TRA choice is independently associated with reduced 30-day mortality outcomes and that the magnitude of this lower mortality risk is not independently influenced by either increases in total procedural volume radial volume or radial proportion at the center level. Finally, our study suggests that higher total volume of procedures and higher proportion of cases undertaken radially at the operator level are independently associated with a larger reduced odds of mortality, with an 11% reduction in the odds for 30-day mortality (compared with TFA use) for each 100 extra procedures performed per year, and an 8% reduction in the odds for 30-day mortality (compared with TFA use) for each 10% increase in the proportion of cases undertaken through the TRA approach.
Previous studies using data derived from randomized controlled trials 14, 15 and data derived from the Veterans Affairs Healthcare system 16 have suggested a relationship between access site outcomes and procedural volumes. Analysis of 24 143 procedures undertaken in 49 Veterans Affairs sites between 2007 and 2010 suggested that the decreased rate of blood transfusions associated with TRA was only observed in high-radial volume centers, defined as performing >50 TRA procedures a year. 16 The RIVAL study reported that in the subgroup of high-volume radial centers, the primary outcome was reduced by TRA versus TFA, but not in intermediate-or low-volume radial centers and there was no significant interaction by individual ORV. 2, 15 In contrast, no significant differences in the primary bleeding end point were observed between the TRA and TFA arm by either ORV, although this study suggests some evidence of a significant interaction at the center level. Subgroup analysis of the RIVAL study by center procedural volume illustrated a significant 8% reduction in the primary end point for overall PCI center volume, a 12% reduction for radial center volume per 50 PCIs/y for median operator at center although this relationship was not observed for mortality outcomes. In a retrospective analysis derived from 8 centers in the United Kingdom, TRA utilization independently predicted decreased 30-day, 6-month, and 1-year mortality in patients undergoing PCI for non-ST-elevated MI indications although this benefit was only observed in high-volume radial centers. 25 Interestingly, in the recent Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) randomized controlled trial, that demonstrated decreases in all-cause mortality, MACE and major Bleeding Academic Research Consortium (BARC) 3 or 5 bleeding rates in the TRA arm, with positive tests for trend across tertiles of the centers' percentage of TRA for PCI for both coprimary outcomes and all-cause mortality, with a particularly pronounced benefit of TRA access in centers that did 80% or more radial PCIs. 26 Our analysis represents the first analysis to systematically study the relationship between TRA volume, total volume, and TRA proportions at both the individual operator and center level in a nationwide setting, where TRA is now the default access route 3, 27 in an unselected real world cohort of patients. We show that access site practice varies according to volume of procedures undertaken at the operator and center level, with increased utilization of the TRA approach because operator and center volume increases. Furthermore, it is interesting to note that we report that the size of the 30-day mortality risk decreases associated with TRA utilization is not independently influenced by center radial or total volume of procedures undertaken, but is independently influenced by OTV and radial proportion. Higher total volume of procedures and higher proportion of cases undertaken radially at the operator level are independently associated with a larger reduced odds of 30-day mortality.
Our analysis represents a broad spectrum of operators with varying access site practice and TRA experience. Previous analyses have been limited in that they have been undertaken in highly selected cohorts of patients in the randomized controlled trial setting undergoing PCI for acute coronary syndrome indications where the highest risk patients such as those with hemodynamic instability where excluded and only experienced operators who undertook at least 50 TRA procedures in the previous year were included in the study. 28 Similarly other studies analyzed data from US cohorts when TRA adoption was <10% at the time points studied and the 5 high volume sites defined as >50 TRA procedures a year averaged 120 TRA procedures a year each which would place these centers in the lowest quartile (2-341 TRA procedures per year) in the current analysis. 16 Our observation that the largest risk reduction associated with the TRA approach is among operators who use TRA in the highest proportion of their cases, and that this is not related to either total volume or radial volume at the center level once other covariates of patient clinical demographics and operator/center experience are adjusted for is of interest. Our previous study has suggested that the greatest mortality reduction associated with TRA adoption is derived from patients at highest baseline bleeding risk, who are often the most hemodynamically unstable, have adverse clinical characteristics such as the elderly, women, or are undergoing PCI for emergent indications, whereas patients at low risk of bleeding complications gain little mortality benefit from adopting a TRA approach. 5 The patients who are likely to gain most from adoption of TRA access site are also those in whom TRA is more challenging. High-proportion TRA operators are likely to use the TRA approach in such patients who are at highest risk of bleeding complications who would derive the greatest mortality benefit from radial access site adoption, whereas low-proportion TRA operators are more likely to use TRA approach in less challenging cases that would derive less/little mortality benefit from utilization of this access site. Radial volume will depend on both the total volume that an operator undertakes and the proportion of cases undertaken through the TRA route; hence, individuals may be high-volume radial operators by virtue of undertaking a large volume of procedures but only undertaking a low proportion of such procedures through the TRA route. Such a high-volume radial operator may only undertake the least challenging cases that would derive a smaller mortality benefit of undertaking the procedure through the TRA approach. Previous literature has only considered radial/total volumes in isolation and not considered the proportion of cases undertaken through the TRA route when examining relationships between radial experience and outcomes. 4,14-16, 25 The more recent MATRIX randomized controlled trial showed a relationship between center TRA proportion and the coprimary outcome, with highest proportion radial centers having the greatest magnitude of benefit in the coprimary outcome, although data around operator proportion was not presented in this analysis. 26 In the highest proportion radial operator and center analysis, we have consistently observed that the cases undertaken through the femoral approach are much sicker, higher risk patients than those undertaken in the lowest proportion operators/centers. For example, at the operator level, in the highest proportion radial operator group cardiogenic shock represented 9.2% of the femoral case mix in contrast to 2.5% in the lowest proportion radial operator group (P<0.001), with similar observations recorded at the center level (7.5% versus 2.3%; P<0.001). In addition, similar findings were observed at both the center and operator volume analyses. It has been previously argued that the more favorable radial outcomes reported at high-proportion radial centers may relate to worse femoral outcomes in these centers at both the center and operator level. 29 Even after removal of the sickest patients such as those with cardiogenic shock in a sensitivity analysis, our findings that lower mortality associated with TRA adoption relates to both the total procedural volume and the proportion of procedures undertaken radially by operator, with operators undertaking the greatest proportion of their procedures radially having the largest relative reduction in mortality risk remain robust. Furthermore, data from the RIVAL have shown that although radial PCI center volume was independently associated with a decrease in the composite primary outcome of death, MI, stroke, noncoronary artery bypass graftingrelated major bleeding at 30 days (hazard ratio, 0.88; 95% CI, 0.80-0.97), femoral PCI center volume was not (hazard ratio, 1.03; 95% CI, 0.94-1.07) suggesting that mechanisms other than worse femoral outcomes in high-volume radial centers contribute to their better outcomes in cases undertaken transradially. 2 Our study has several potential limitations. Although mortality tracking within England and Wales is robust, the cause of mortality is not available; and all other outcomes and complications such as major bleeding events are self-reported and are not formally audited by BCIS, subjecting the data to reporting biases. Second, we were unable to account for crossover in access site because these data are not captured in the BCIS data set. Finally, although we have attempted to correct for differences in baseline and procedural demographics observed between the TFA and TRA cohorts using a variety of statistical techniques, the relationship between access site and favorable outcomes does not infer causality, and unmeasured confounders may contribute to the unfavorable outcomes observed in the TFA cohort.
In conclusion, in the largest analysis to date undertaken nationally to systematically study access site-related outcomes and procedural volumes at both the operator and institutional level, we demonstrate that the lower mortality associated with TRA adoption relates to the proportion of procedures undertaken through the radial approach, and also the total volume of procedures, with operators undertaking the greatest proportion of their procedures radially having the largest relative reduction in mortality risk. We observe that the reduced mortality associated with TRA does not relate to either total volume or radial volume at the center level once other covariates of patient clinical demographics and operator experience are adjusted for.
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